Onconetix Inc. Common Stock (ONCO)
Stock · NASDAQ · Health Care
$0.612as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$1.5
Industry
Biotechnology: Pharmaceutical Preparations
How Onconetix Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Jun 2, 2025 · via SEC EDGAR / Finnhub
Onconetix Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ONCOOnconetix Inc. Common Stock$0.6121▼ 3.15%Market cap $2.99MP/E —
- SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares$3▼ 13.29%Market cap $2.94MP/E —$3.1$83,758
- SXTP60 Degrees Pharmaceuticals Inc. Common Stock$1.03▼ 2.83%Market cap $3.08MP/E —$1.01$8.62
- ARTLArtelo Biosciences Inc. Common Stock$0.6619▲ 0.14%Market cap $2.59MP/E —$0.52$28.14
- SBFMSunshine Biopharma Inc. Common Stock$1.16▼ 8.66%Market cap $2.48MP/E —$1.01$24.3
- OGENOragenics Inc. Common Stock$0.5296▼ 0.08%Market cap $2.39MP/E —$0.4801$1.45
- PPCBPropanc Biopharma Inc. Common Stock$1.4▼ 37.22%Market cap $3.68MP/E —$0.95$85.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ONCO Onconetix Inc. Common Stock | $2.99M | — | $0.6121 | ▼ 3.15% | |
| SXTC China SXT Pharmaceuticals Inc. Class A Ordinary Shares | $2.94M | — | $3 | ▼ 13.29% | $3.1$83,758 |
| SXTP 60 Degrees Pharmaceuticals Inc. Common Stock | $3.08M | — | $1.03 | ▼ 2.83% | $1.01$8.62 |
| ARTL Artelo Biosciences Inc. Common Stock | $2.59M | — | $0.6619 | ▲ 0.14% | $0.52$28.14 |
| SBFM Sunshine Biopharma Inc. Common Stock | $2.48M | — | $1.16 | ▼ 8.66% | $1.01$24.3 |
| OGEN Oragenics Inc. Common Stock | $2.39M | — | $0.5296 | ▼ 0.08% | $0.4801$1.45 |
| PPCB Propanc Biopharma Inc. Common Stock | $3.68M | — | $1.4 | ▼ 37.22% | $0.95$85.5 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.